Recent Advances in Zika Virus Vaccines

被引：32

作者：

Garg, Himanshu ^{[1
]}

Mehmetoglu-Gurbuz, Tugba ^{[1
]}

Joshi, Anjali ^{[1
]}

机构：

[1] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Emphasis Infect Dis, El Paso, TX 79905 USA

来源：

VIRUSES-BASEL | 2018年 / 10卷 / 11期

关键词：

Zika virus; flaviviruses; vaccines; virus like particles; clinical trials; ZIKV; RECOMBINANT SUBVIRAL PARTICLES; NEUTRALIZING IMMUNE-RESPONSES; PROTECTIVE EFFICACY; ENCEPHALITIS-VIRUS; MESSENGER-RNA; DNA VACCINE; MICE; PROTEINS; IMMUNOGENICITY; IMMUNIZATION;

D O I：

10.3390/v10110631

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The recent outbreaks of Zika virus (ZIKV) infections and associated microcephaly in newborns has resulted in an unprecedented effort by researchers to target this virus. Significant advances have been made in developing vaccine candidates, treatment strategies and diagnostic assays in a relatively short period of time. Being a preventable disease, the first line of defense against ZIKV would be to vaccinate the highly susceptible target population, especially pregnant women. Along those lines, several vaccine candidates including purified inactivated virus (PIV), live attenuated virus (LAV), virus like particles (VLP), DNA, modified RNA, viral vectors and subunit vaccines have been in the pipeline with several advancing to clinical trials. As the primary objective of Zika vaccination is the prevention of vertical transmission of the virus to the unborn fetus, the safety and efficacy requirements for this vaccine remain unique when compared to other diseases. This review will discuss these recent advances in the field of Zika vaccine development.

引用

页数：13

共 50 条

[21] Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E [J].

Xiong, Guoqing ;

Li, Yi ;

Chen, Fei ;

Xiong, Xianghua ;

Wang, Qingyang ;

Zhang, Liancheng ;

Dong, Haolong ;

Zhu, Chen ;

Cui, Jiazhen ;

He, Meijuan ;

Cheng, Hao ;

Hu, Ao ;

Cheng, Chunlin ;

Pang, Jinglun ;

Liu, Gang ;

Chen, Huipeng .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113

[22] Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines [J].

Correia Carabineiro, Sonia Alexandra .

MOLECULES, 2017, 22 (05)

[23] Cervical cancer vaccines: Recent advances in HPV research [J].

Eiben, GL ;

Da Silva, DM ;

Fausch, SC ;

Le Poole, IC ;

Nishimura, MI ;

Kast, WM .

VIRAL IMMUNOLOGY, 2003, 16 (02) :111-121

[24] Nanotherapeutic systems for delivering cancer vaccines: recent advances [J].

Beg, Sarwar ;

Alharbi, Khalid S. ;

Alruwaili, Nabil K. ;

Alotaibi, Nasser Hadal ;

Almalki, Waleed H. ;

Alenezi, Sattam K. ;

Altowayan, Waleed M. ;

Alshammari, Mohammed S. ;

Rahman, Mahfoozur .

NANOMEDICINE, 2020, 15 (15) :1527-1537

[25] Recent advances in the study of zika virus structure, drug targets, and inhibitors [J].

Feng, Yingqi .

FRONTIERS IN PHARMACOLOGY, 2024, 15

[26] An Indian Perspective of Some Recent Developments in Polio, DPT, Zika and Rotavirus Vaccines [J].

Iyer, Vidhya V. ;

Tejal, A. ;

Poddar, A. ;

Maithili, D. ;

Rasika, L. G. ;

Bendre, A. ;

Jaswal, Vani .

INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 79 (02) :175-185

[27] Recent research advances in the development of Dabie Banda virus vaccines [J].

Yu, Chenyang ;

Lin, Yuxiang ;

Dai, Yixin ;

Wu, Bingan ;

Qi, Zhongtian ;

Qian, Xijing .

PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (08)

[28] Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure [J].

Andrade, Daniela V. ;

Harris, Eva .

VIRUS RESEARCH, 2018, 254 :27-33

[29] Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates [J].

Suschak, John J. ;

Schmaljohn, Connie S. .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) :2359-2377

[30] Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation [J].

Kim, Eun ;

Erdos, Geza ;

Huang, Shaohua ;

Kenniston, Thomas ;

Falo, Louis D., Jr. ;

Gambotto, Andrea .

EBIOMEDICINE, 2016, 13 :315-320

← 1 2 3 4 5 →